Position in GH
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$837,917
+$341,706 QoQ
Shares Held
5,585
+4.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#335
of 594 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ethic Inc. holds $75,114,951 across 18 Diagnostics & Research names. GH ranks #13 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
48,517 | $24,324,483 | |
| 2 | DHR |
Danaher Corp /De/
|
72,929 | $13,891,515 | |
| 3 | DGX |
Quest Diagnostics Inc
|
31,253 | $6,624,073 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
10,542 | $5,549,730 | |
| 5 | WAT |
Waters Corp /De/
|
10,608 | $3,978,424 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
19,677 | $3,801,989 | |
| 7 | ILMN |
Illumina, Inc.
|
18,070 | $3,177,248 | |
| 8 | A |
Agilent Technologies, Inc.
|
21,259 | $2,823,832 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $837,917 | 5,585 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $496,211 | 5,372 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $547,266 | 5,358 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $240,860 | 3,855 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $221,742 | 4,261 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||